{
    "2021-02-03": [
        [
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)拉升涨超9%两条新冠疫苗技术路线取得进展",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "新冠疫苗",
                        "技术路线",
                        "进展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "创业板指涨超1%，康泰生物、阳光电源、宁德时代涨幅靠前",
                "features": {
                    "keywords": [
                        "创业板指",
                        "康泰生物",
                        "阳光电源",
                        "宁德时代",
                        "涨幅靠前"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "新能源"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物2月月报：寻业绩主线 重点关CXO等高增长赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩主线",
                        "CXO",
                        "高增长赛道"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}